Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

OBJECTIVE: Many studies have shown the efficacy of everolimus after pretreatment with vascular endothelial growth factor receptor-tyrosine kinase inhibitors. We investigated the efficacy and safety of everolimus as a second-line treatment after the failure of vascular endothelial growth factor recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Oyama, Masafumi, Sugiyama, Takayuki, Nozawa, Masahiro, Fujimoto, Kiyohide, Kishida, Takeshi, Kimura, Go, Tokuda, Noriaki, Hinotsu, Shiro, Shimozuma, Kojiro, Akaza, Hideyuki, Ozono, Seiichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448062/
https://www.ncbi.nlm.nih.gov/pubmed/28334974
http://dx.doi.org/10.1093/jjco/hyw194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448062/
https://www.ncbi.nlm.nih.gov/pubmed/28334974
http://dx.doi.org/10.1093/jjco/hyw194

Ejemplares similares